期刊文献+

血清骨膜蛋白、呼出气一氧化氮、痰及血嗜酸性粒细胞与哮喘的相关性研究 被引量:4

Study on the relationship between serum periosteal protein, exhaled nitric oxide, induced sputum, blood eosinophils and asthma
下载PDF
导出
摘要 目的:观察哮喘患者血清骨膜蛋白浓度,探讨其与呼出气一氧化氮(FeNO)水平、诱导痰及外周血嗜酸性粒细胞(EOS)计数、肺功能指标第1秒用力呼气量(FEV1)占预计值(FVC)百分比的关系及其临床意义。方法:选择包头医学院第二附属医院呼吸内科病房哮喘急性发作期的患者65例作为哮喘组及门诊健康体检者25例作为健康组,分别检测两组患者的血清骨膜蛋白浓度、呼出气一氧化氮水平、外周血嗜酸性粒细胞百分比及肺功能FEV1/FVC;显微镜进行细胞分类及计数检测诱导痰EOS计数;Pearson直线相关分析血清骨膜蛋白与其他指标的相关性。结果:哮喘组患者血清骨膜蛋白浓度、FeNO水平及外周血和痰EOS百分比均高于健康组,哮喘组FEV1/FVC低于健康组(P<0.05);哮喘组患者血清骨膜蛋白浓度与FeNO水平、外周血及痰EOS百分比均呈正相关(r=0.565,P=0.000;r=0.541,P=0.000;r=0.268,P=0.000),与FEV1/FVC呈负相关性(r=-0.101,P=0.061);FeNO水平与外周血及痰EOS百分比均呈正相关(r=0.284,P=0.000;r=0.340,P=0.000);与FEV1/FVC无明显相关性(r=0.040,P=0.051)。结论:哮喘患者急性发作期血清骨膜蛋白浓度明显升高,FeNO水平也增高,可反映哮喘患者气道炎症水平,尤其是嗜酸性粒细胞性炎症。 Objective:To observe the concentration of serum periosteal protein in patients with asthma and to explore the relationship between serum periosteal protein and exhaled nitric oxide (FeNO) level, induced sputum and peripheral blood eosinophils (EOS) count, lung function index forced inspiratory volume in1second (FEV1) as a percentage of predicted (FVC) and its clinical significance. Methods: 65 patients with acute attack of asthma in the Department of Respiratory Medicine, the second affiliated Hospital of Baotou Medical College were selected as the asthma group and 25 healthy outpatients as the healthy group. The concentration of serum periosteal protein, the level of exhaled nitric oxide, the percentage of eosinophils in peripheral blood and pulmonary function FEV1/FVC were measured by light microscope to detect the EOS count of induced sputum. The correlation between serum periosteal protein and other indexes was analyzed by Pearson linear correlation analysis. Results: The concentration of serum periosteal protein, the level of FeNO and the percentage of EOS in peripheral blood and sputum in the asthma group were higher than those in the healthy group, and the FEV1/FVC in the asthma group was lower than that in the healthy group. In asthma group, the concentration of serum periosteal protein was positively correlated with the level of FeNO and the percentage of EOS in peripheral blood and sputum ( r =0.565, P =0.000, r =0.541, P =0.000), and negatively correlated with FEV1/FVC ( r =-0.101, P =0.061). The level of FeNO was positively correlated with the percentage of EOS in peripheral blood and sputum ( r =0.284, P =0.000;r =0.340, P =0.000). There was no significant correlation with FEV1/FVC ( r =0.040, P =0.051). Conclusion: The concentration of serum periosteal protein and the level of FeNO in patients with asthma are significantly higher than those in patients with asthma, which can reflect the level of airway inflammation, especially eosinophilic inflammation in patients with asthma.
作者 关淑英 高扬 蔡志平 时静华 杜晓 荣淑慧 GUAN Shuying;GAO Yang;CAI Zhiping;SHI Jinghua;DU Xiao;RONG Shuhui(Baotou Medical College of Inner Mongolia University of Scienceand Technology, Baotou 014060,China;Second Affiliated Hospital of Baotou Medical College of Inner Mongolia University of Science and Technology)
出处 《包头医学院学报》 CAS 2019年第4期14-16,共3页 Journal of Baotou Medical College
基金 包头医学院科学研究基金项目(BYJJ-YF201628)
关键词 哮喘 血清骨膜蛋白 呼出气一氧化氮 血嗜酸粒细胞 Asthma Serum periosteal protein Exhaled nitric oxide Blood eosinophils
  • 相关文献

参考文献1

二级参考文献28

  • 1Bateman ED,Hurd SS,Barnes PJ,et al. Global strategy for asthma management and prevention: GINA executive summary [J]. Eur Respir J,2008,31 ( 1 ) :143-178.
  • 2Douglas G, Higgins B, Barnes N, et al. British Guideline on the Management of Asthma[ J ]. Thorax,2008,63 Suppl 4 : ivl -iv121.
  • 3Hamelmann E. The rationale for treating allergic asthma with anti- IgE[ J]. Eur Respir Rev,2007,16(104) :61-66.
  • 4Walker S, Monteil M, Phelan K, et al. Anti-IgE for chronic asthma in adults and children [ J 1. Cochrane Database Syst Rev, 2006,19 (2) : CD003559.
  • 5Rodrigo GJ, Neffen H, Castro-Rodriguez JA, et al. Efficacy and safety of subcutaneous Omalizumab vs placebo as Add-on therapy to corticosteroids for children and adults with Asthma [ J ]. Chest, 2011,139( 1 ) :28-35.
  • 6Corren J,Casale TB,Lanier B,et al. Safety and tolerability of Oma- lizumab [ J ]. Clin Exp Allergy, 2009,39 ( 6 ) :788 -797.
  • 7Aidan AL, James EF, Abdelkader R, et al. Baseline characteristics of patients enrolled in EXCELS : a cohort study [ J ]. Ann Allergy Asthma Immunol,2009,103(3) :212-219.
  • 8Omalizumab : potential risk of arterial thrombotic events [ J/OL ]. Drug $afetyUpdate,2011,4(7) :A4.
  • 9Bateman ED,Izquierdo JL,Harnest U,et al. Efficacy and safety of roflumilast in the treatment of asthma[ J]. Ann Allergy Asthma Ira-.muno1,2006,96 ( 5 ) :679-686.
  • 10Bahadori K, Quon BS, Doyle-Waters MM, et al. A systematic review of economic evaluations therapy in asthma [ J ]. J Asthma Allergy, 2010,3:33,42.

共引文献99

同被引文献35

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部